Academic Journal
Q1Lung
About Lung
Lung is a scholarly journal published by Springer. SCImago 2025 lists it in Q1, with an SJR of 1.034 and H-index of 78.
Coverage: 1959, 1964, 1976-2026. Research categories: Pulmonary and Respiratory Medicine (Q1).
Verified field sources
- Journal Impact Factor: 4.3 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Peter Dicpinigaitis MD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Tuberculosis Research and Epidemiology; Mycobacterium research and diagnosis; Pleural and Pulmonary Diseases; Chronic Obstructive Pulmonary Disease (COPD) Research; Infectious Diseases and Tuberculosis; Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,290.00 USD; 3,290.00 EUR; 2,890.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Author’s Response to: Nebulised Heparin for Lung Disease: Three Overlooked Risks that Merit Study Before Chronic Clinical Use
Margarid Miranda, Marc Brown, Frank MP van Haren, Bethany Brown et al.
2026-10-03 · DOI: 10.1007/s00408-026-00938-3Menthol for the Relief of Dyspnea: A Systematic Review of Randomized Controlled Trials
Kuheli Das Gupta, Kay Choong See
2026-09-18 · DOI: 10.1007/s00408-026-00926-7Nebulised Heparin for Lung Disease: Three Overlooked Risks that Merit Study Before Chronic Clinical Use
Fajar Farid, Haider Imran
2026-09-18 · DOI: 10.1007/s00408-026-00937-4GLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps
Laith Allaham, Baylee King, Fahiye Ali, Ishita Gupta et al.
2026-09-16 · DOI: 10.1007/s00408-026-00939-2Defining Early Recurrence in Resectable Non-small Cell Lung Cancer Using Post-Recurrence Survival
Wara Naeem, Arsalan A. Khan, Erik E. Rabin, Sierra Broad et al.
2026-09-16 · DOI: 10.1007/s00408-026-00934-7Dupilumab Alleviates Pulmonary Fibrosis by Interrupting Profibrotic Macrophage-Fibroblast Crosstalk and IL4R/JAK/STAT Signaling
Qi Chen, Yupei Zhang, Shiyang Wang, Ruxuan Chen et al.
2026-09-16 · DOI: 10.1007/s00408-026-00936-5Unveiling BRAF Mutations in Non-small Cell Lung Cancer: State of the Art and Future Perspectives
Maria Colombino, Panagiotis Paliogiannis, Grazia Palomba, Marina Pisano et al.
2026-09-16 · DOI: 10.1007/s00408-026-00932-9Inhalable Dry Powders of Antimicrobial Agents in Respiratory Diseases
Hasham Shafi, David Encinas-Basurto, Y. Peter Di, Heidi M. Mansour et al.
2026-09-16 · DOI: 10.1007/s00408-026-00931-wAdult-Onset Interstitial Lung Disease Due to Homozygous SFTPB Variant
Claudio Tirelli, Niamh Logan, Krunal Mahida, Felix Chua et al.
2026-09-16 · DOI: 10.1007/s00408-026-00940-9Obstructive Sleep Apnea in Individuals with Alpha-1 Antitrypsin Deficiency: A Single Center Experience
Leela Krishna Teja Boppana, Xueya Cai, Michael Schweitzer, Michael Yurcheshen et al.
2026-09-11 · DOI: 10.1007/s00408-026-00935-6A Scoping Literature Review of Digital Measures and Patient-Reported Outcomes for Refractory/Unexplained Chronic Cough: Assessment of Clinical Trials and Real-World Clinical Practice
Elizabeth P. Skinner, Rafael Alfonso-Cristancho, Atish De, Brian Leinwand et al.
2026-09-10 · DOI: 10.1007/s00408-026-00928-5Review of the Utilization of GLP-1 and GLP-1/GIP in Adults with Cystic Fibrosis
Morgan C. Jones, Abagail Opsal, Ashley Buige
2026-09-02 · DOI: 10.1007/s00408-026-00929-4Cough Hypersensitivity in Gastroesophageal Reflux-Induced Chronic Cough: Insights from Reflux Monitoring and High-Resolution Manometry
Yaxing Zhou, Siwan Wen, Yunfeng Zhang, Tongyangzi Zhang et al.
2026-09-02 · DOI: 10.1007/s00408-026-00933-8Optimizing Inhaled Corticosteroid Prescribing in COPD: Evaluating the Impact of Eosinophil Testing on Clinical Outcomes
Jared Hester, David Whipkey, James Ferrell
2026-08-29 · DOI: 10.1007/s00408-026-00930-xUpdate 2026: Management of Small Cell Lung Cancer
Mumtu Lalla, Puneet Dhillon, Buse Eglenen Polat, Haiying Cheng et al.
2026-08-19 · DOI: 10.1007/s00408-026-00927-6Clinical Relevance of Serum Inducible and Endothelial Nitric Oxide Synthase Ratio for Pulmonary Hypertension in Acute Exacerbated Chronic Obstructive Pulmonary Disease
Yating Zhang, Dongrui Zhang, Wei Jia, Yi Li et al.
2026-08-18 · DOI: 10.1007/s00408-026-00922-xElevated Pleural Fluid IL-9 as a Diagnostic Biomarker for Differentiating Tuberculous from Lung Adenocarcinoma-Associated Malignant Pleural Effusions
Huili Zhou, Shaobing Wang, Qunshan Huang, Tiantian Liu et al.
2026-08-16 · DOI: 10.1007/s00408-026-00925-8Fatigue, Muscular Performance, and Quadriceps Fiber Type Profile in Lymphangioleiomyomatosis and Healthy Matched Controls
Mary Beth Brown, Claire E. Child, Paul Kim, Morgan L. Kelly et al.
2026-08-16 · DOI: 10.1007/s00408-026-00916-9Malnutrition Severity, Morphofunctional Assessment, and Survival in Patients with Lung Cancer: A Multicentre Prospective Cohort Study
Pablo Rodríguez de Vera-Gómez, María Galindo-Gallardo, María González-Pacheco, Alba Carmona-Llanos et al.
2026-08-14 · DOI: 10.1007/s00408-026-00924-9Identification of ZNF331 as a Biomarker for Obstructive Sleep Apnea in Idiopathic Pulmonary Fibrosis Through Integrated Bioinformatics Analysis and Clinical Validation
Shuo Wang, Yanwen Zhang, Jihong Feng, Jing Feng et al.
2026-08-10 · DOI: 10.1007/s00408-026-00921-yReviews
Community Reviews
Version History
October 2, 2026 at 8:25 pm
October 2, 2026